Omega Diagnostics Share Discussion Threads

[riz000] 28/10/2020 08:09

“X KING OF TAJ MAHAL” 👑


Relax ladies n gents Stop panicking!!!

This will rise later on back to 90s again


Hello Tickboo u back in Odx?

[tickboo] 28/10/2020 08:04

Also by the looks of it antibody tests are not looking the best bet given how long immunity lasts. It is all about antigen tests so a good thing ODX is developing one, well Mologic is but they will manufacture it.

[g2theary] 28/10/2020 08:03

Buy at 50p :)

[tickboo] 28/10/2020 07:56

Financials a mess but cash in the bank more than enough given the likely revenue increase in the near term.Antigen test likely to commence validation in Feb then as tech transfer will take a couple of months. The antigen test a lot more complicated than antibody.

[gwr7] 28/10/2020 07:50

There will be a few looking green this morning.

[hodhasharon] 28/10/2020 07:46

Is that the GreenRichard thread you're referring to?

[thejaba] 28/10/2020 07:45

tom @TomInvestorUK

#ODX
£1.7M loss
£7M cash
£166Mcap

[eggy toast] 28/10/2020 07:43

'SIGNIFICANTLY increase in revenue is the word to look at'

Not exactly hard to improve the revenue is it.

What happened to India?

[thejaba] 28/10/2020 07:40

9 degrees

its not a false statement its what the rns says.

[buywell3] 28/10/2020 07:38

A lot of eggs on faces soon thinks buywell

I like eggs

But on a plate --- fried

[gwr7] 28/10/2020 07:37

Where's the jam? Best of british to all on the softie thread :-)

[rivaldo] 28/10/2020 07:34

Just one extract:

"the Company remains on track to increase capacity to produce up to 200,000 AbC-19(TM) Rapid tests per week by the end of November, with the capacity contributing to the overall target of 300,000 lateral flow tests per week mentioned above"

The historic numbers are pretty irrelevant in the scheme of things - though the core Food Intolerance business is recovering well anyway in H2. Interestingly, ODX state there are "significant near-term opportunities for this business unit in China". News flow is imminent here perhaps.

The ELISA test update is slightly disappointing, but ODX are "optimistic that it will see further orders materialise from DHSC and other sources, both domestic and overseas" as regards Abingdon.

Re the Mologic lateral flow antibody test, "we are seeing early sales traction with this product that provides confidence for performance in the second half of the financial year."

Finally, the antigen test is looking good : "by the end of November, Omega would look to commence technical transfer of the test prior to commencing manufacturing".

The m/cap here is still small imo if prospects start to become tangible as hoped.

[onehanded] 28/10/2020 07:30

SIGNIFICANTLY increase in revenue is the word to look at. Forward not backwards.... Would make a nice bolt on for another bigger company to buy..

[barrywhit] 28/10/2020 07:29

RNS as expected, still lots of cash and ramping up LFT's as expected. ELISA testing sales disappointing....CD4-200 progressing and Food Intolerance heading in the right direction....

[amaretto1] 28/10/2020 07:28

COVID will never go !!This is the new world .. I'm afraid.

[9degrees] 28/10/2020 07:28

thejaba you make a false statement ."Revenue is £3m" . Think about it that makes £6m in a year as these results are for 6 months

[hodhasharon] 28/10/2020 07:27

Great RNS imho.

[thejaba] 28/10/2020 07:16

no matter how you dress this up the facts are MC 120m, revenue 3m.

Covid has brought a huge disconnect for some companies, once Covid goes its back down to earth for a lot.

[amaretto1] 28/10/2020 07:12

The future is significant revenues !!

[onehanded] 27/10/2020 14:48

is now a takeover target, would fit a larger pharmaceutical company or add to a antigen company profile. I saw a few rumours circulating, but would need to see large buys if true.

[valuetracker] 27/10/2020 14:45

Value Target (ODX): 166-177p

[rivaldo] 27/10/2020 13:38

Tomorrow is a trading update, not the results - it's all about the outlook, progress re COVID tests, progress re CD4, progress in China for Food Intolerance etc. The historic numbers are almost irrelevant.

[upomega] 27/10/2020 12:30

Maybe its better that we are drifting today.The results may surprise us. Hopefully in a good way

[control1] 27/10/2020 12:15

Struggling again when others up, hope this isn't a harbinger of tomorrow's presentation (or the much speculated placing).....